Experimental drug is helpful against c. diff, animal study finds

Share this article:
An experimental compound, which investigators say could be used as an alternative to antibiotics, has been shown to be effective in fighting Clostridium difficile in laboratory mice.

The compound mimics a natural cellular defense mechanism that neutralizes the toxins that cause c. difficile. The disease, which causes severe diarrhea, is one of the most common healthcare-acquired infections and can prove deadly in elderly nursing home residents.

In laboratory studies, conducted by investigators at University of California, Los Angeles, Case Western Reserve University, Tufts University and the Commonwealth Medical College and the University of Texas Medical Branch at Galveston, mice treated with the compound became less ill and were more likely to survive C. diff infection than untreated mice, according to the study.

"This may prove to be an alternative to antibiotics," study author Tor Savidge, M.D., told Reuters, adding that more study is needed.

The study was published in the journal Nature Medicine.

Share this article:

More in News

MedPAC discusses limiting patients' post-acute options

MedPAC discusses limiting patients' post-acute options

Medicare rules might have to be relaxed to give hospitals more say in where patients go for post-acute care, members of the Medicare Payment Advisory Commission proposed at a recent ...

Nursing home workers told not to touch residents due to Ebola concerns

U.S. nursing home workers who hail from West Africa are being stigmatized as potential Ebola carriers and forbidden from touching residents, according to IRIN, an independent news service launched by the United Nations Office for the Coordination of Humanitarian Affairs.

Former office manager charged with embezzling half a million dollars from residents

The former business office manager of a Michigan nursing home has been charged with embezzling more than $460,000 from the resident trust fund, the state's attorney general announced last Thursday.